BILE ACIDS
Basic Information
- Primary DI
- 06975225462718
- Basic UDI-DI Code
- B-06975225462718
- Reference
- DTSH020108
- Device Types
- None provided
- Regulation
- Eu Ivdd
- Classification
- Eu Ivd General
- Status
- On The Market
- Manufacturer
- Da Te Bioengineering Technology Co., LTD.
Additional Description
This kit is intended for the in vitro quantitative detection of total bile acid (TBA) in human serum. TBA levels were significantly higher in patients with acute hepatitis, even more than 10 to 100 times the normal level. In patients with chronic hepatitis, if TBA levels is above 20 μmol/L, it should be diagnosed as chronic active hepatitis. Serum TBA was significantly higher when alcoholic liver disease generate serious liver injury, and mild, moderate damage increase is not obvious. Determination of serum TBA in the diagnosis of liver toxicity than conventional liver function tests. Extrahepatic bile duct obstruction, intrahepatic cholestasis including acute hepatitis, biliary cirrhosis early, neonatal cholestasis, cholestasis of pregnancy etc. lead TBA increased.
CND Nomenclature Codes
| Code | Description |
|---|---|
| W01010202 | BILE ACIDS |
Available In Countries
Similar Devices
Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).